Literature summary for 2.3.1.97 extracted from

Jacquier, M.; Kuriakose, S.; Bhardwaj, A.; Zhang, Y.; Shrivastav, A.; Portet, S.; Varma Shrivastav, S.
Investigation of novel regulation of N-myristoyltransferase by mammalian target of rapamycin in breast cancer cells (2018), Sci. Rep., 8, 12969 .

Search for more literature for 2.3.1.97

Application

Application	Comment	Organism
medicine	upon inhibition of mTOR by treating MCF7 cells with rapamycin, the expression of NMT1 increases with rapamycin treatment over the period of time with a concomitant decrease in mTOR phosphorylation. Activated mammalian target of rapamycin (mTOR) is positively associated with overall survival and recurrence free survival in ER positive breast cancer patients who were later treated with tamoxifen	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	P30419	isoform NMT1	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)